Investors Number: 5.0
Funding Status: Early Stage Venture
Headquarters: Paris, Ile-de-France, France
Last Funding Date: 2022-09-02
Founded Date: 2019-01-01
Last Funding Type: Series A
Total Funding: 6000000.0
Industry: Early Drug Development